1 Min Read
March 28 (Reuters) - Knight Therapeutics Inc -
* Assigned its secured loan issued to Pro Bono Bio Plc and has received full repayment of balance Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.